outcome_descr,brand_descr,stratum,model,model_descr,term,HR,HR_CI,VE,VE_CI,HR_ECI,VE_ECI
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.32,(0.28-0.37),67.7,(63.3-71.6),0.32 (0.28-0.37),67.7 (63.3-71.6)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.49,(0.44-0.54),51.2,(45.9-55.9),0.49 (0.44-0.54),51.2 (45.9-55.9)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.59,(0.54-0.65),40.9,(35.3-46.0),0.59 (0.54-0.65),40.9 (35.3-46.0)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.50,(0.44-0.55),50.5,(44.7-55.6),0.50 (0.44-0.55),50.5 (44.7-55.6)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.40,(0.35-0.46),59.6,(53.7-64.7),0.40 (0.35-0.46),59.6 (53.7-64.7)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.36,(0.31-0.43),63.6,(57.2-69.1),0.36 (0.31-0.43),63.6 (57.2-69.1)
"Positive
SARS-CoV-2
test",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.38,(0.32-0.44),62.4,(56.2-67.8),0.38 (0.32-0.44),62.4 (56.2-67.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.32,(0.28-0.36),68.4,(64.1-72.2),0.32 (0.28-0.36),68.4 (64.1-72.2)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.48,(0.43-0.53),52.5,(47.4-57.1),0.48 (0.43-0.53),52.5 (47.4-57.1)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.57,(0.52-0.62),42.9,(37.5-47.8),0.57 (0.52-0.62),42.9 (37.5-47.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.47,(0.42-0.53),52.6,(47.1-57.5),0.47 (0.42-0.53),52.6 (47.1-57.5)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.38,(0.34-0.44),61.7,(56.2-66.5),0.38 (0.34-0.44),61.7 (56.2-66.5)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.34,(0.29-0.40),65.7,(59.7-70.8),0.34 (0.29-0.40),65.7 (59.7-70.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.35,(0.30-0.41),64.7,(59.0-69.6),0.35 (0.30-0.41),64.7 (59.0-69.6)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.34,(0.30-0.38),66.2,(61.5-70.3),0.34 (0.30-0.38),66.2 (61.5-70.3)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.51,(0.46-0.56),49.0,(43.5-54.0),0.51 (0.46-0.56),49.0 (43.5-54.0)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.62,(0.56-0.68),38.2,(32.4-43.5),0.62 (0.56-0.68),38.2 (32.4-43.5)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.52,(0.46-0.58),48.2,(42.2-53.6),0.52 (0.46-0.58),48.2 (42.2-53.6)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.43,(0.37-0.49),57.4,(51.3-62.8),0.43 (0.37-0.49),57.4 (51.3-62.8)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.39,(0.33-0.45),61.4,(54.7-67.2),0.39 (0.33-0.45),61.4 (54.7-67.2)
"Positive
SARS-CoV-2
test",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.40,(0.34-0.46),60.1,(53.6-65.7),0.40 (0.34-0.46),60.1 (53.6-65.7)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.29,(0.24-0.36),70.6,(64.3-75.9),0.29 (0.24-0.36),70.6 (64.3-75.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.51,(0.44-0.58),49.3,(41.7-55.9),0.51 (0.44-0.58),49.3 (41.7-55.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.52,(0.46-0.59),47.7,(40.9-53.7),0.52 (0.46-0.59),47.7 (40.9-53.7)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.38,(0.33-0.45),61.8,(55.5-67.2),0.38 (0.33-0.45),61.8 (55.5-67.2)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.34,(0.28-0.40),66.5,(59.9-72.0),0.34 (0.28-0.40),66.5 (59.9-72.0)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.32,(0.26-0.40),67.8,(60.3-73.9),0.32 (0.26-0.40),67.8 (60.3-73.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.37,(0.31-0.44),63.4,(56.1-69.4),0.37 (0.31-0.44),63.4 (56.1-69.4)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.29,(0.24-0.35),71.3,(65.0-76.5),0.29 (0.24-0.35),71.3 (65.0-76.5)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.50,(0.43-0.57),50.3,(42.8-56.8),0.50 (0.43-0.57),50.3 (42.8-56.8)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.51,(0.45-0.58),48.6,(42.0-54.5),0.51 (0.45-0.58),48.6 (42.0-54.5)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.38,(0.32-0.44),62.5,(56.3-67.8),0.38 (0.32-0.44),62.5 (56.3-67.8)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.33,(0.27-0.39),67.2,(60.7-72.6),0.33 (0.27-0.39),67.2 (60.7-72.6)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.31,(0.26-0.39),68.5,(61.2-74.4),0.31 (0.26-0.39),68.5 (61.2-74.4)
"Positive
SARS-CoV-2
test",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.36,(0.30-0.42),64.4,(57.5-70.2),0.36 (0.30-0.42),64.4 (57.5-70.2)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.30,(0.25-0.37),69.7,(63.0-75.1),0.30 (0.25-0.37),69.7 (63.0-75.1)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.53,(0.46-0.61),47.0,(39.0-54.0),0.53 (0.46-0.61),47.0 (39.0-54.0)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.55,(0.49-0.63),44.6,(37.4-50.9),0.55 (0.49-0.63),44.6 (37.4-50.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.41,(0.35-0.48),59.2,(52.5-64.9),0.41 (0.35-0.48),59.2 (52.5-64.9)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.37,(0.31-0.44),63.2,(56.0-69.3),0.37 (0.31-0.44),63.2 (56.0-69.3)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.36,(0.29-0.44),64.3,(56.0-71.0),0.36 (0.29-0.44),64.3 (56.0-71.0)
"Positive
SARS-CoV-2
test",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.40,(0.34-0.48),59.9,(52.0-66.5),0.40 (0.34-0.48),59.9 (52.0-66.5)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.34,(0.29-0.40),66.1,(60.0-71.2),0.34 (0.29-0.40),66.1 (60.0-71.2)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.45,(0.39-0.52),55.0,(48.5-60.7),0.45 (0.39-0.52),55.0 (48.5-60.7)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.58,(0.52-0.65),41.7,(34.7-47.9),0.58 (0.52-0.65),41.7 (34.7-47.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.50,(0.44-0.58),49.6,(42.1-56.2),0.50 (0.44-0.58),49.6 (42.1-56.2)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.38,(0.32-0.45),62.0,(54.9-68.0),0.38 (0.32-0.45),62.0 (54.9-68.0)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.33,(0.27-0.40),67.2,(59.7-73.3),0.33 (0.27-0.40),67.2 (59.7-73.3)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.36,(0.30-0.43),63.8,(56.7-69.7),0.36 (0.30-0.43),63.8 (56.7-69.7)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.33,(0.28-0.39),66.7,(60.8-71.8),0.33 (0.28-0.39),66.7 (60.8-71.8)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.44,(0.39-0.51),55.8,(49.4-61.3),0.44 (0.39-0.51),55.8 (49.4-61.3)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.58,(0.51-0.64),42.4,(35.6-48.5),0.58 (0.51-0.64),42.4 (35.6-48.5)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.50,(0.44-0.57),50.0,(42.6-56.4),0.50 (0.44-0.57),50.0 (42.6-56.4)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.38,(0.32-0.45),62.2,(55.1-68.1),0.38 (0.32-0.45),62.2 (55.1-68.1)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.33,(0.27-0.40),67.3,(59.8-73.3),0.33 (0.27-0.40),67.3 (59.8-73.3)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.36,(0.31-0.44),63.5,(56.5-69.4),0.36 (0.31-0.44),63.5 (56.5-69.4)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.36,(0.30-0.42),64.4,(58.0-69.9),0.36 (0.30-0.42),64.4 (58.0-69.9)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.48,(0.42-0.55),52.3,(45.4-58.4),0.48 (0.42-0.55),52.3 (45.4-58.4)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.63,(0.56-0.70),37.1,(29.7-43.8),0.63 (0.56-0.70),37.1 (29.7-43.8)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.56,(0.48-0.64),44.4,(36.2-51.6),0.56 (0.48-0.64),44.4 (36.2-51.6)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.43,(0.36-0.51),57.4,(49.5-64.1),0.43 (0.36-0.51),57.4 (49.5-64.1)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.37,(0.30-0.46),62.8,(54.1-69.7),0.37 (0.30-0.46),62.8 (54.1-69.7)
"Positive
SARS-CoV-2
test",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.41,(0.34-0.49),58.8,(50.6-65.6),0.41 (0.34-0.49),58.8 (50.6-65.6)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.28,(0.24-0.34),71.6,(65.9-76.4),0.28 (0.24-0.34),71.6 (65.9-76.4)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.31,(0.26-0.37),68.9,(63.5-73.6),0.31 (0.26-0.37),68.9 (63.5-73.6)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.41,(0.36-0.47),58.6,(52.9-63.7),0.41 (0.36-0.47),58.6 (52.9-63.7)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.35,(0.30-0.41),64.8,(58.9-69.9),0.35 (0.30-0.41),64.8 (58.9-69.9)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.25,(0.20-0.30),75.1,(69.7-79.5),0.25 (0.20-0.30),75.1 (69.7-79.5)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.23,(0.18-0.29),77.3,(71.4-82.0),0.23 (0.18-0.29),77.3 (71.4-82.0)
"COVID-19
hospitalisation",Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.21,(0.17-0.26),79.4,(74.4-83.4),0.21 (0.17-0.26),79.4 (74.4-83.4)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.26,(0.22-0.32),73.7,(68.4-78.1),0.26 (0.22-0.32),73.7 (68.4-78.1)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.28,(0.24-0.33),71.7,(66.7-75.9),0.28 (0.24-0.33),71.7 (66.7-75.9)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.37,(0.32-0.42),63.5,(58.4-67.9),0.37 (0.32-0.42),63.5 (58.4-67.9)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.30,(0.26-0.35),70.0,(65.0-74.4),0.30 (0.26-0.35),70.0 (65.0-74.4)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.21,(0.17-0.25),79.4,(75.0-83.1),0.21 (0.17-0.25),79.4 (75.0-83.1)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.18,(0.15-0.23),81.6,(76.8-85.4),0.18 (0.15-0.23),81.6 (76.8-85.4)
"COVID-19
hospitalisation",Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.16,(0.13-0.20),83.7,(79.9-86.8),0.16 (0.13-0.20),83.7 (79.9-86.8)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.35,(0.28-0.44),64.6,(55.6-71.8),0.35 (0.28-0.44),64.6 (55.6-71.8)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.37,(0.31-0.45),62.7,(55.0-69.1),0.37 (0.31-0.45),62.7 (55.0-69.1)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.50,(0.44-0.57),50.1,(42.8-56.4),0.50 (0.44-0.57),50.1 (42.8-56.4)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.42,(0.36-0.49),57.8,(50.6-64.0),0.42 (0.36-0.49),57.8 (50.6-64.0)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.31,(0.24-0.39),69.0,(60.6-75.6),0.31 (0.24-0.39),69.0 (60.6-75.6)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.26,(0.20-0.33),74.3,(67.2-79.8),0.26 (0.20-0.33),74.3 (67.2-79.8)
"COVID-19
hospitalisation",Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.22,(0.17-0.28),77.9,(72.0-82.5),0.22 (0.17-0.28),77.9 (72.0-82.5)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.23,(0.17-0.31),77.1,(69.0-83.1),0.23 (0.17-0.31),77.1 (69.0-83.1)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.27,(0.21-0.35),72.8,(65.2-78.7),0.27 (0.21-0.35),72.8 (65.2-78.7)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.36,(0.30-0.44),63.6,(56.4-69.6),0.36 (0.30-0.44),63.6 (56.4-69.6)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.23,(0.18-0.29),76.8,(70.6-81.6),0.23 (0.18-0.29),76.8 (70.6-81.6)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.15,(0.11-0.20),84.9,(79.6-88.8),0.15 (0.11-0.20),84.9 (79.6-88.8)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.19,(0.14-0.26),81.3,(74.4-86.4),0.19 (0.14-0.26),81.3 (74.4-86.4)
"COVID-19
hospitalisation",BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.22,(0.17-0.28),78.1,(71.6-83.1),0.22 (0.17-0.28),78.1 (71.6-83.1)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.21,(0.15-0.29),79.0,(71.4-84.5),0.21 (0.15-0.29),79.0 (71.4-84.5)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.25,(0.19-0.32),75.1,(68.1-80.6),0.25 (0.19-0.32),75.1 (68.1-80.6)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.33,(0.28-0.40),66.9,(60.2-72.4),0.33 (0.28-0.40),66.9 (60.2-72.4)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.21,(0.16-0.26),79.1,(73.6-83.5),0.21 (0.16-0.26),79.1 (73.6-83.5)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.13,(0.10-0.18),86.7,(82.0-90.2),0.13 (0.10-0.18),86.7 (82.0-90.2)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.16,(0.12-0.22),83.9,(77.9-88.3),0.16 (0.12-0.22),83.9 (77.9-88.3)
"COVID-19
hospitalisation",BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.18,(0.14-0.24),81.5,(76.1-85.7),0.18 (0.14-0.24),81.5 (76.1-85.7)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.29,(0.20-0.42),71.3,(58.1-80.3),0.29 (0.20-0.42),71.3 (58.1-80.3)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.36,(0.25-0.53),63.5,(47.2-74.8),0.36 (0.25-0.53),63.5 (47.2-74.8)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.44,(0.37-0.53),55.5,(46.6-63.0),0.44 (0.37-0.53),55.5 (46.6-63.0)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.31,(0.24-0.39),69.5,(60.9-76.2),0.31 (0.24-0.39),69.5 (60.9-76.2)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.24,(0.15-0.40),75.8,(60.0-85.4),0.24 (0.15-0.40),75.8 (60.0-85.4)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.24,(0.17-0.33),76.0,(66.8-82.7),0.24 (0.17-0.33),76.0 (66.8-82.7)
"COVID-19
hospitalisation",BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.27,(0.20-0.36),73.0,(64.4-79.6),0.27 (0.20-0.36),73.0 (64.4-79.6)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.32,(0.26-0.40),67.6,(59.5-74.0),0.32 (0.26-0.40),67.6 (59.5-74.0)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.33,(0.27-0.40),67.2,(59.8-73.2),0.33 (0.27-0.40),67.2 (59.8-73.2)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.40,(0.34-0.48),59.6,(52.4-65.7),0.40 (0.34-0.48),59.6 (52.4-65.7)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.38,(0.31-0.46),62.4,(54.5-68.9),0.38 (0.31-0.46),62.4 (54.5-68.9)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.27,(0.21-0.34),73.2,(66.1-78.8),0.27 (0.21-0.34),73.2 (66.1-78.8)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.21,(0.16-0.28),79.1,(72.2-84.4),0.21 (0.16-0.28),79.1 (72.2-84.4)
"COVID-19
hospitalisation",ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.20,(0.15-0.26),80.1,(74.4-84.6),0.20 (0.15-0.26),80.1 (74.4-84.6)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.30,(0.24-0.38),69.7,(62.1-75.7),0.30 (0.24-0.38),69.7 (62.1-75.7)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.31,(0.25-0.37),69.5,(62.7-75.1),0.31 (0.25-0.37),69.5 (62.7-75.1)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.37,(0.32-0.44),62.7,(56.2-68.3),0.37 (0.32-0.44),62.7 (56.2-68.3)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.34,(0.28-0.41),65.7,(58.5-71.6),0.34 (0.28-0.41),65.7 (58.5-71.6)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.24,(0.19-0.30),76.0,(69.6-81.0),0.24 (0.19-0.30),76.0 (69.6-81.0)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.18,(0.14-0.25),81.6,(75.4-86.2),0.18 (0.14-0.25),81.6 (75.4-86.2)
"COVID-19
hospitalisation",ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.17,(0.13-0.22),82.7,(77.7-86.5),0.17 (0.13-0.22),82.7 (77.7-86.5)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.40,(0.31-0.53),59.9,(47.5-69.4),0.40 (0.31-0.53),59.9 (47.5-69.4)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.39,(0.32-0.47),61.3,(52.6-68.4),0.39 (0.32-0.47),61.3 (52.6-68.4)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.52,(0.44-0.62),47.7,(38.2-55.8),0.52 (0.44-0.62),47.7 (38.2-55.8)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.49,(0.41-0.59),50.9,(40.6-59.4),0.49 (0.41-0.59),50.9 (40.6-59.4)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.35,(0.27-0.44),65.4,(55.9-72.8),0.35 (0.27-0.44),65.4 (55.9-72.8)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.26,(0.19-0.35),74.1,(65.2-80.8),0.26 (0.19-0.35),74.1 (65.2-80.8)
"COVID-19
hospitalisation",ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.23,(0.17-0.30),77.4,(70.3-82.7),0.23 (0.17-0.30),77.4 (70.3-82.7)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.11,(0.09-0.14),89.0,(85.9-91.4),0.11 (0.09-0.14),89.0 (85.9-91.4)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.15,(0.13-0.18),84.7,(81.7-87.2),0.15 (0.13-0.18),84.7 (81.7-87.2)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.18,(0.16-0.21),81.9,(79.3-84.1),0.18 (0.16-0.21),81.9 (79.3-84.1)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.20,(0.18-0.23),79.7,(76.9-82.1),0.20 (0.18-0.23),79.7 (76.9-82.1)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.18,(0.16-0.21),82.0,(79.3-84.3),0.18 (0.16-0.21),82.0 (79.3-84.3)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.21,(0.19-0.24),78.7,(75.6-81.5),0.21 (0.19-0.24),78.7 (75.6-81.5)
Any death,Any vaccine,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.23,(0.20-0.25),77.5,(74.7-79.9),0.23 (0.20-0.25),77.5 (74.7-79.9)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.11,(0.09-0.14),88.9,(85.8-91.4),0.11 (0.09-0.14),88.9 (85.8-91.4)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.15,(0.13-0.18),84.7,(81.7-87.2),0.15 (0.13-0.18),84.7 (81.7-87.2)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.18,(0.16-0.20),82.1,(79.6-84.3),0.18 (0.16-0.20),82.1 (79.6-84.3)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.20,(0.17-0.22),80.5,(77.8-82.8),0.20 (0.17-0.22),80.5 (77.8-82.8)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.17,(0.15-0.19),83.3,(80.8-85.4),0.17 (0.15-0.19),83.3 (80.8-85.4)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.19,(0.17-0.22),80.8,(78.0-83.3),0.19 (0.17-0.22),80.8 (78.0-83.3)
Any death,Any vaccine,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.19,(0.17-0.21),81.3,(78.9-83.4),0.19 (0.17-0.21),81.3 (78.9-83.4)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.15,(0.12-0.20),84.7,(80.2-88.2),0.15 (0.12-0.20),84.7 (80.2-88.2)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.22,(0.18-0.26),78.1,(73.7-81.7),0.22 (0.18-0.26),78.1 (73.7-81.7)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.30,(0.26-0.36),69.5,(63.9-74.3),0.30 (0.26-0.36),69.5 (63.9-74.3)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.32,(0.28-0.37),67.7,(63.1-71.7),0.32 (0.28-0.37),67.7 (63.1-71.7)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.28,(0.24-0.32),72.3,(67.9-76.0),0.28 (0.24-0.32),72.3 (67.9-76.0)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.32,(0.27-0.37),68.2,(63.0-72.8),0.32 (0.27-0.37),68.2 (63.0-72.8)
Any death,Any vaccine,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.29,(0.25-0.33),70.9,(66.6-74.6),0.29 (0.25-0.33),70.9 (66.6-74.6)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.06,(0.03-0.10),94.0,(89.7-96.5),0.06 (0.03-0.10),94.0 (89.7-96.5)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.12,(0.08-0.16),88.5,(84.2-91.6),0.12 (0.08-0.16),88.5 (84.2-91.6)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.12,(0.10-0.15),87.8,(84.8-90.1),0.12 (0.10-0.15),87.8 (84.8-90.1)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.12,(0.10-0.15),87.8,(85.0-90.1),0.12 (0.10-0.15),87.8 (85.0-90.1)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.13,(0.11-0.16),87.0,(84.1-89.4),0.13 (0.11-0.16),87.0 (84.1-89.4)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.15,(0.12-0.18),85.4,(82.2-88.0),0.15 (0.12-0.18),85.4 (82.2-88.0)
Any death,BNT162b2,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.23,(0.20-0.26),77.0,(73.8-79.8),0.23 (0.20-0.26),77.0 (73.8-79.8)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.06,(0.03-0.10),94.2,(90.0-96.6),0.06 (0.03-0.10),94.2 (90.0-96.6)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.11,(0.08-0.15),88.8,(84.6-91.8),0.11 (0.08-0.15),88.8 (84.6-91.8)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.12,(0.10-0.15),88.0,(85.1-90.4),0.12 (0.10-0.15),88.0 (85.1-90.4)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.12,(0.10-0.15),88.2,(85.4-90.4),0.12 (0.10-0.15),88.2 (85.4-90.4)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.12,(0.10-0.15),87.8,(85.1-90.1),0.12 (0.10-0.15),87.8 (85.1-90.1)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.13,(0.11-0.16),86.9,(84.0-89.3),0.13 (0.11-0.16),86.9 (84.0-89.3)
Any death,BNT162b2,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.19,(0.16-0.22),81.3,(78.5-83.7),0.19 (0.16-0.22),81.3 (78.5-83.7)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.07,(0.04-0.13),92.7,(87.3-95.8),0.07 (0.04-0.13),92.7 (87.3-95.8)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.16,(0.11-0.22),84.1,(78.1-88.5),0.16 (0.11-0.22),84.1 (78.1-88.5)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.22,(0.15-0.32),77.9,(68.3-84.6),0.22 (0.15-0.32),77.9 (68.3-84.6)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.20,(0.16-0.25),79.8,(74.8-83.7),0.20 (0.16-0.25),79.8 (74.8-83.7)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.22,(0.18-0.27),78.3,(73.1-82.5),0.22 (0.18-0.27),78.3 (73.1-82.5)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.23,(0.19-0.28),77.1,(71.7-81.5),0.23 (0.19-0.28),77.1 (71.7-81.5)
Any death,BNT162b2,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.30,(0.26-0.35),69.9,(64.9-74.2),0.30 (0.26-0.35),69.9 (64.9-74.2)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",1-3,0.14,(0.11-0.18),86.0,(81.5-89.4),0.14 (0.11-0.18),86.0 (81.5-89.4)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",4-7,0.17,(0.14-0.21),82.6,(78.6-85.8),0.17 (0.14-0.21),82.6 (78.6-85.8)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",8-14,0.21,(0.18-0.24),79.2,(75.9-82.0),0.21 (0.18-0.24),79.2 (75.9-82.0)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",15-21,0.23,(0.20-0.27),76.8,(73.2-80.0),0.23 (0.20-0.27),76.8 (73.2-80.0)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",22-28,0.18,(0.16-0.22),81.6,(78.4-84.3),0.18 (0.16-0.22),81.6 (78.4-84.3)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",29-35,0.23,(0.19-0.27),77.3,(73.4-80.7),0.23 (0.19-0.27),77.3 (73.4-80.7)
Any death,ChAdOx1,NA,1,"Region-stratified Cox model, with no further adjustment",36+,0.24,(0.22-0.28),75.6,(72.3-78.4),0.24 (0.22-0.28),75.6 (72.3-78.4)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",1-3,0.14,(0.10-0.18),86.3,(81.9-89.6),0.14 (0.10-0.18),86.3 (81.9-89.6)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",4-7,0.17,(0.14-0.21),83.0,(79.1-86.1),0.17 (0.14-0.21),83.0 (79.1-86.1)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",8-14,0.20,(0.18-0.23),79.7,(76.5-82.5),0.20 (0.18-0.23),79.7 (76.5-82.5)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",15-21,0.22,(0.19-0.26),77.6,(74.1-80.6),0.22 (0.19-0.26),77.6 (74.1-80.6)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",22-28,0.17,(0.15-0.21),82.5,(79.5-85.1),0.17 (0.15-0.21),82.5 (79.5-85.1)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",29-35,0.21,(0.18-0.25),79.1,(75.4-82.2),0.21 (0.18-0.25),79.1 (75.4-82.2)
Any death,ChAdOx1,NA,2,"Region-stratified Cox model, with adjustment for baseline confounders",36+,0.21,(0.18-0.24),79.2,(76.3-81.8),0.21 (0.18-0.24),79.2 (76.3-81.8)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",1-3,0.19,(0.14-0.25),80.9,(74.6-85.6),0.19 (0.14-0.25),80.9 (74.6-85.6)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",4-7,0.24,(0.20-0.30),75.6,(69.9-80.3),0.24 (0.20-0.30),75.6 (69.9-80.3)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",8-14,0.33,(0.28-0.40),66.7,(60.3-72.1),0.33 (0.28-0.40),66.7 (60.3-72.1)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",15-21,0.36,(0.31-0.42),63.5,(57.6-68.6),0.36 (0.31-0.42),63.5 (57.6-68.6)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",22-28,0.28,(0.24-0.33),71.8,(66.6-76.2),0.28 (0.24-0.33),71.8 (66.6-76.2)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",29-35,0.34,(0.29-0.40),66.0,(59.5-71.5),0.34 (0.29-0.40),66.0 (59.5-71.5)
Any death,ChAdOx1,NA,4,"Region-stratified marginal structural Cox model, with adjustment for baseline and time-varying confounders",36+,0.31,(0.27-0.36),68.8,(63.8-73.1),0.31 (0.27-0.36),68.8 (63.8-73.1)
